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The coevolution of myxoma virus and the wild European rabbit in Australia and the development of resistance to
myxomatosis in wild rabbits have been well described. However, the mechanism of resistance to myxomatosis in wild rabbits
is not understood. To determine the basis of resistance, the pathogenesis of the virulent standard laboratory strain (SLS) and
the attenuated Uriarra (Ur) strain of myxoma virus were examined in Australian wild rabbits that have been naturally selected
in the field for resistance to myxomatosis and in laboratory rabbits which have never been selected for resistance. Virus was
localized in tissue sections by immunofluorescence. In all cases virus antigen was initally present in dendritic cells of the
dermis before localizing predominantly to the epidermis by Day 6. Antigen-containing cells were detected in the lymph nodes
by 24 h after inoculation. Virus replication occurred predominantly in T lymphocytes of the paracortex but SLS also replicated
in germinal centers. SLS replication induced loss of most lymphocytes from the lymph nodes of susceptible rabbits.
Apoptosis of lymphocytes within the lymph nodes was a major feature of all infections. These apoptotic cells did not contain
detectable viral antigen but were often adjacent to infected cells. Ongoing apoptosis of lymphocytes within lymph nodes was
also a feature of the recovery phase when very few or no virus-infected cells could be detected. Differences between virulent
and attenuated viruses in the wild and laboratory rabbits were predominantly in the degree of tissue pathology in the draining
lymph node and distal lymph node and in the type of inflammatory responses, particularly in the skin. SLS infection of
laboratory rabbits was associated with a very mild inflammatory response, often distant from the site of virus replication and
comprised predominantly of neutrophils. In contrast, Ur-infected rabbits and SLS-infected wild rabbits had an intense
inflammatory response adjacent to the site of virus replication and this was comprised predominantly of mononuclear cells.
Both the initial infection of dendritic cells and the ongoing destruction of lymphocytes provide obvious mechanisms for the
suppression of the immune response by myxoma virus. © 2000 Academic Press
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Adaptation to a new host may drive the evolution of
both an emerging pathogen and its new host. One of the
best-studied examples of host-virus coevolution is the
release of myxoma virus for biological control of the wild
European rabbit population of Australia and the subse-
quent selection for rabbits with resistance to myxomato-
sis and attenuated strains of virus The coevolution of
myxoma virus and the European rabbit in Australia was
extensively studied as it occurred and has formed the
basis for conceptual and mathematical models of infec-
tious disease evolution (Anderson and May, 1982; Fen-
ner, 1983). However, remarkably little is understood
about either the mechanism of resistance in the rabbit or
the attenuation of the virus (reviewed by Kerr and Best,
1998).
1 Current address: NIAID NIH Rocky Mountain Laboratories, 903
outh 4th St, Hamilton, MT 59840.
2 To whom correspondence and reprint requests should be ad-
dressed at CSIRO Wildlife and Ecology, G.P.O. Box 284, Canberra, ACT
2601, Australia. Fax: 61 2 62421511. E-mail: p.kerr@dwe.csiro.au.
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
76Myxoma virus is a poxvirus (genus: leporipoxvirus).
Two subtypes of the virus have been described. The
south American type is found in Sylvilagus brasiliensis
(forest rabbits) and the Californian type in S. bachmani
(brush rabbits) (Fenner and Ross, 1994). In its normal
host species, myxoma virus replication induces a cuta-
neous fibroma at the site of inoculation. The virus is
probably not disseminated systemically. Myxoma virus is
spread by biting arthropods such as fleas and mosqui-
toes which pick up the virus as they probe through the
skin lesion. Transmission is passive as myxoma virus
does not replicate within the vector. High virus titers in
the skin are thus critical for transmission (Fenner and
Ross, 1994). A virulent strain of myxoma virus from Brazil
(the standard laboratory strain, SLS) was released in
Australia in 1950.
In the European rabbit (Oryctolagus cuniculus), myx-
oma virus causes the lethal disease myxomatosis char-
acterized by systemic spread of the virus and the devel-
opment of secondary skin lesions (myxomas). Following
intradermal inoculation, myxoma virus replicates in the
skin at the inoculation site and spreads from there to the
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77CELLULAR LOCALIZATION OF MYXOMA VIRUSdraining lymph node. The virus replicates to high titers in
the lymph node and spreads in infected leukocytes to
distal tissues such as the spleen, testis, lung, and mu-
cocutaneous sites, such as the nose and conjunctivae,
and skin (Fenner and Woodroofe, 1953; Best and Kerr,
2000). The major sites of pathology are the lymphoid
tissues and skin, although some alterations occur in
most organs (Hurst, 1937). The main pathological fea-
tures are cellular proliferation and cellular necrosis. An
unusual feature of the pathology of myxoma virus infec-
tion is the proliferation of cells in the walls of the small
blood vessels and the appearance of large stellate “myx-
oma cells” (Hurst, 1937).
To study the mechanism of resistance to myxoma
virus, we have used the original SLS (standard laboratory
strain) myxoma virus and an attenuated field strain (Uri-
arra, Ur) to infect unselected laboratory rabbits (to rep-
resent the original host susceptibility) and naturally se-
lected wild resistant rabbits. We have killed rabbits from
each of the four groups at 12 and 24 h and 2, 4, 6, and 10
days after infection and from three of the groups at 15
and 20 days after infection. Thus we have directly com-
pared virulent and attenuated virus strains in resistant
and susceptible outbred rabbits. This paper describes
which cells virus was infecting, the clearance of virus
from the tissues, cell death, and inflammatory re-
sponses. Histopathological differences between the vir-
ulent and attenuated viruses and the wild and laboratory
rabbits are described. The spread of virus and replica-
tion of these strains of myxoma virus in resistant and
susceptible rabbits was described in a previous paper
(Best and Kerr, 2000).
RESULTS
Clinical disease in laboratory and wild rabbits
infected with SLS and Ur
The clinical disease in laboratory and wild rabbits
infected with SLS or Ur has been described in detail
elsewhere (Best and Kerr, 2000). Laboratory rabbits in-
oculated with SLS developed very severe myxomatosis.
These rabbits were not kept for longer than 10 days as
previous experience showed that they would all die be-
tween 10 and 14 days after inoculation (Robinson et al.,
999). Wild rabbits inoculated with SLS also developed
evere myxomatosis but the clinical signs were delayed
ompared to laboratory rabbits and the animals recov-
red rapidly starting around Days 12 to 15. Laboratory
abbits inoculated with the attenuated Ur strain of myx-
ma virus developed quite severe clinical myxomatosis
ith the peak clinical signs between Days 12 and 15.
hey began to recover between Days 15 and 20. Wild
abbits inoculated with Ur had a very mild infection
haracterized by a primary lesion at the inoculation site
nd mild conjunctival swelling and mild anogenital in-
lammation.The main differences in histopathology and virus local-
ization between the laboratory and the wild rabbits infected
with virulent SLS or attenuated Ur strains of myxoma virus
are summarized in Table 1 and are described in detail
below. The histology of SLS infection has been previously
described (Hurst, 1937) and is only briefly described here to
highlight differences between the infections.
Virus replication in dermis and epidermis
Following intradermal inoculation, myxoma virus rep-
lication was detected by immunofluorescence in the der-
mis at the inoculation site at 24 h but not at 12 h after
intradermal inoculation. The infected cells were elon-
gated, had prominent cell processes, and were located
either at the epidermal-dermal junction or deeper in the
dermis. At 2 and 4 days after infection the dermis was
packed with virus-infected cells (Fig. 1A). These cells
stained positively for MHC-II. In uninfected rabbits,
MHC-II-positive cells were located predominantly at the
junction of the epidermis and dermis (Fig. 1B). However
at 4 days after infection MHC-II-positive cells were
largely in the dermis (Fig. 1C). Smaller mononuclear
cells, probably lymphocytes, within the dermis were also
positive for virus in wild rabbits infected with SLS but not
in the other infections. At Day 6 in all infections, virus
was no longer present in MHC-II-positive cells but was
concentrated in the epidermis, within round cells in the
dermis and for SLS-infected laboratory rabbits only, large
rectangular cells proximal to dermal blood vessels (see
below in Fig. 3Diii). Also in SLS-infected laboratory rab-
bits, virus was present within the subdermal muscle
layers but this was not the case in wild rabbits. By 10
days after infection, the majority of cells staining positive
for virus were in the epidermis, including the cells of the
hair follicles, rather than the dermis (Fig. 1D).
The colocalization of virus with MHC-II antigen-posi-
tive cells was confirmed by double staining (Fig. 2).
In all infections with SLS or Ur in wild or laboratory
rabbits, virus replication initially occurred within MHC-II-
positive cells in the skin. However, there were clear
differences between wild and laboratory rabbits and SLS
and Ur in the extent and timing of subsequent pathology
and particularly in the inflammatory responses in the
dermis and epidermis. These differences could be seen
as early as Day 4 when there was a mononuclear cell
infiltrate in the dermis of all infections, but in SLS-in-
fected laboratory rabbits the cells were confined to the
lower dermis. By Day 6 the dermis of the inoculation site
of Ur in laboratory rabbits and both viruses in wild rabbits
contained large numbers of macrophages, lymphocytes,
and plasma cells concentrated within the upper dermis
with aggregates of cells at the epidermal/dermal junction
directly below areas of epidermal pathology that stained
positively for virus. The cells of this inflammatory re-
sponse were similar in Ur-infected laboratory rabbits and
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78 BEST, COLLINS, AND KERRSLS- and Ur-infected wild rabbits but there were always
more mononuclear cells in the dermis of wild rabbits. In
contrast, inflammatory cells in the dermis of SLS-infected
laboratory rabbits were predominantly polymorphs with
some lymphocytes and macrophages. These cells were
frequently karyorrhectic or apoptotic and were aggre-
gated deep in the dermis adjacent to the superficial
muscle. Myxoma virus was detected by immunofluores-
cence at this location in laboratory rabbits infected with
either SLS or Ur but not in wild rabbits.
Differences in the inflammatory response and pathol-
ogy between infections were marked by 10 days after
T
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mostly of polymorphs (Fig. 3A). This is in contrast with
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79CELLULAR LOCALIZATION OF MYXOMA VIRUSVirus was able to persist in the skin in laboratory
rabbits infected with Ur and in wild rabbits infected with
SLS or Ur. At Day 15, virus was present in the epidermis
although there were fewer infected cells compared to
Day 10. The epithelial cells of the external root sheath of
the hair follicles were strongly positive for virus. At this
stage many epidermal cells were necrotic and large
vesicles had formed in the epidermis giving a similar
appearance to SLS at Day 10. Fragmented cell debris
was common within the epidermis and a scab was
forming on the surface. At Day 20, there was a thick scab
over the inoculation site and virus was present only in
the basal layer of the epidermis and in the epithelial cells
of the hair follicles. There was a massive aggregration of
inflammatory cells at the margins of the scab and within
the dermis the density and organization of collagen fi-
bers had increased as had fibroblast numbers. Extrava-
sated red blood cells were a prominent feature.
A further difference in SLS-infected laboratory rabbits
from the other infections was the appearance of large
cells in the walls of small blood vessels, which were
FIG. 1. Immunofluorescence staining for myxoma virus and MHC-II i
after infection of a laboratory rabbit with SLS. Cells staining positive fo
and epidermis (E). Scale bar, 200 mm. (B) MHC-II-positive cells in the
epidermal/dermal junction where the majority of positive cells are loca
epidermis; D, dermis). Scale bar, 200 mm. (D) Virus staining at Day 10disrupted with extravasated red cells leaking into the
surrounding tissues. These cells appeared to be migrat-ing into the surrounding tissues of the dermis where they
were frequently surrounded by polymorphs (Figs. 3Di
and 3Dii). Virus antigen was present in endothelial cells
of blood vessels and within the large migrating cells
clustered around these vessels (Fig. 3Diii). These cells
are presumably the “myxoma cells” described by Hurst
(1937), although whether they are all derived from the
one progenitor type has not been determined. These
cells did not stain for MHC-II and neither did endothelial
cells. Endothelial cells were enlarged in the other infec-
tions but in general no further changes were detected
and there was no virus detected within the endothelial
cells in these infections. Large stellate myxoma cells
were also uncommon in the other infections.
Virus replication in the lymph node draining the
inoculation site
We had previously demonstrated that the popliteal
lymph node predominantly drained the foot inoculation
site (Best and Kerr, 2000). SLS in laboratory or wild
kin of the inoculation site of SLS-infected laboratory rabbits. (A) Day 4
(white) are localized to the dermis (D) and the junction of the dermis
rmis (E) and dermis (D) of an uninfected rabbit. Arrow indicates the
ale bar, 200 mm. (C) MHC-II-positive cells at Day 4 after infection (E,
fection (E, epidermis; D, dermis). Scale bar, 100 mm.n the s
r virus
epiderabbits or Ur in laboratory rabbits was detected in the
draining lymph node at 24 h after infection. Virus was
80 BEST, COLLINS, AND KERRpresent in cells of the paracortex directly under the
subcapsular sinus. Antigen with high fluorescence inten-
sity was within the cytoplasm of cells. There were also
lines of low fluorescence intensity antigen which did not
appear to be cell associated and may have represented
aggregated virus or antigen complexes draining to the
node from the inoculation site. Ur was not detected in
wild rabbits until 48 h after infection but was then also in
cells of the paracortex (this was the only time at which Ur
was detected in the draining lymph node of wild rabbits).
At 2 days, virus was present in lines of cells, predomi-
nantly lymphocytes, under the capsule of the lymph
node, and spanning the paracortex (Figs. 4A and B). This
FIG. 2. Immunofluorescence staining to colocalize viral antigen and
MHC-II in dermal cells at Day 4 from an SLS-infected laboratory rabbit.
(A) Double-stained image of dermis showing viral antigen (green) and
MHC-II (red). Costaining shows as yellow. Arrow indicates single cell
magnified in B. Scale bar, 80 mm. (B) Magnification and artificial color
separation of arrowed cell in A. Viral antigen is represented by green,
MHC-II antigen by red. Scale bar, 10mm.led to a generalized infection of the lymphocytes of the
cortex and paracortex (Figs. 4C, D, and E). From 4 daysafter infection, large elongate cells within the wall of the
capsule stained positive for virus in laboratory rabbits
infected with SLS (Fig. 4F) but this was not a feature of
other infections. During infection of the draining lymph
node SLS infections had consistently greater numbers of
virus-infected cells in the node than were present in the
other infections and these were evenly distributed
throughout the cortex of the node and within the follicles.
In draining lymph nodes from the other infections there
were areas with high densities of infected cells but also
other areas with few or no infected cells and virus-
infected cells were not normally found within the folli-
cles.
In all infections, virus replication predominantly oc-
curred in the T cell zone of the lymph node. In SLS-
infected laboratory rabbits this was associated with dra-
matic depletion of the lymphocytes, proliferation of retic-
ular cells, and an influx of inflammatory cells. There was
also an intial lymphocyte depletion in wild rabbits in-
fected with SLS. Swelling of the endothelial cells of small
blood vessels was present in both wild and laboratory
rabbits infected with SLS by Day 4. Stellate myxoma cells
were also a feature of lymph nodes from SLS-infected
laboratory and wild rabbits. By Day 6 after infection,
similar pathological changes were occurring in the para-
cortex and germinal centers of both wild and laboratory
rabbits infected with SLS and there were high numbers
of neutrophils in the subcapsular sinus and the sur-
rounding connective tissue. Depletion of lymphocytes
was more localized in wild rabbits and the extent of
lymphocyte loss varied greatly between rabbits. Figure
5A shows the loss of lymphocytes from a laboratory
rabbit lymph node infected with SLS (compare with Fig.
5C which is similar to a normal lymph node). In addition,
there has been an influx of polymorphs and there are
changes in the walls of small blood vessels similar to
those described in the dermis. Figure 5B depicts the
same time point in a severely affected wild rabbit and
shows that while there has been a large-scale loss of
lymphocytes there are still lymphocytes present and
there are far fewer polymorphs than in the laboratory
rabbits infected with SLS. Lymph nodes in wild rabbits
were particularly variable at Day 10 with pathology rang-
ing from extensive lymphocyte depletion and reticular
cell proliferation to relatively normal tissue. In laboratory
rabbits infected with Ur, lymphocyte depletion was not
observed and there were few polymorphs (Fig. 5C). By
Day 15, the lymph nodes of wild rabbits inoculated with
SLS were well populated with lymphocytes (Fig. 5D) and
virus could not be detected by immunofluorescence. In
Ur-infected laboratory rabbits, virus was only present in
a few lymphocytes at Day 15 and was not present at Day
20. In Ur-infected wild rabbits, viral antigen was not
present after Day 2.
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81CELLULAR LOCALIZATION OF MYXOMA VIRUSVirus replication in the contralateral lymph node
Virus was detected at Day 4 in the contralateral node
FIG. 3. Histopathology of inoculation site from myxoma virus infected
D, dermis). Scale bar, 200 mm. (B) SLS-infected wild rabbit 10 days
laboratory rabbit 10 days after infection (E, epidermis; D, dermis). Scale
Scale bar, 25 mm. (Dii) Myxoma cell (filled arrow) and surrounding polym
myxoma virus antigen in cells around the blood vessel wall. VE, vascufor both laboratory and wild rabbits infected with SLS. At
Day 6 virus was detected in cells migrating from bloodvessels into the contralateral lymph node and in cells
migrating within the subcapsular sinus of the lymph
. (A) SLS-infected laboratory rabbit Day 10 after infection (E, epidermis;
fection (E, epidermis; D, dermis). Scale bar, 200 mm. (C) Ur-infected
0 mm. (Di) Myxoma cells (arrow heads) budding off blood vessel walls.
(hollow arrows). Scale bar, 25 mm. (Diii) Immunofluorescence showing
othelium; L, blood vessel lumen. Scale bar, 25 mm.rabbits
after in
bar, 20node (Fig. 6). This suggests that this node is infected
both by virus-infected lymphocytes from the bloodstream
r , 80 mm
ell in ly
82 BEST, COLLINS, AND KERRand by virus-infected cells draining from other sites such
as the skin. Viral antigen was detected in the contralat-
eral node in Ur-infected laboratory rabbits consistently
from Day 6 and was cleared between 10 and 15 days
after infection. Viral antigen was only detected in the
contralateral lymph node of wild rabbits infected with Ur
at Day 10.
The pathology in the contralateral lymph node of SLS-
infected laboratory rabbits was similar to that in the
draining node. There was a generalized depletion of
lymphocytes from the paracortex, a proliferation of retic-
ular cells, and an influx of polymorphs. This was in
contrast to the SLS-infected wild rabbits, which had very
minor pathological changes in the contralateral lymph
node during infection. Similarly, neither wild nor labora-
FIG. 4. Immunofluorescence staining of myxoma virus infection of ly
after infection. Infected cells (arrowed) directly under the subcapsular s
50 mm. (B) SLS infection of laboratory rabbit: draining lymph node Day
mm. (C) SLS-infected wild rabbit: draining lymph node Day 6. Generalize
abbit: contralateral lymph node Day 4. GC, germinal center. Scale bar
SLS-infected laboratory rabbit: Day 4. High magnification of infected ctory rabbits infected with Ur had significant pathological
changes in the contralateral nodes, which were wellpopulated with lymphocytes and had active germinal
center formation.
A further obvious difference between the infections was
the development of germinal centers in the lymph nodes. In
Ur-infected rabbits, at 4 days after infection there was a
large number of follicles developing into germinal centers,
up to 40 per tissue section. This was much greater than for
SLS-infected rabbits where a maximum of 8 developing
follicles was found. In SLS-infected wild rabbits the forma-
tion of germinal centers was limited in the draining lymph
node but in the contralateral node germinal center forma-
tion was similar although not quite as extensive as it was in
the Ur-infected rabbits. Germinal center formation seemed
to be inversely related to virus replication as one Ur-in-
fected rabbit had no development of germinal centers in the
des. (A) SLS infection of laboratory rabbit: draining lymph node Day 2
). P, paracortex; C, connective tissue around the lymph node. Scale bar,
r infection. Lines of infected cells in the paracortex (P). Scale bar, 150
tion of the paracortex (P). Scale bar, 200 mm. (D) Ur-infected laboratory
. (E) SLS-infected lymphocyte high magnification. Scale bar, 8 mm. (F)
mph node capsule. Scale bar, 20 mm.mph no
inus (S
2 afte
d infeccontralateral node at Day 6 but it had more virus-infected
cells than any of the other rabbits.
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The spleen was not a major site of myxoma virus
replication in any infection as determined by the number
FIG. 5. Histological appearance of draining lymph node of myxoma vir
lood vessel. Arrow heads indicate polymorphs. Scale bar, 100 mm. (B)
mm. (C) Ur-infected laboratory rabbit: Day 10. Scale bar, 100 mm. (D) Sof virus-positive cells. Viral antigen was detected within
lymphocytes and macrophages in the spleen of labora-tory rabbits infected with either SLS or Ur at Day 6 but
was not detected at any time point in wild rabbits.
The pathological changes in the spleen resembled
those in the lymph nodes but were not as severe. There
cted rabbits. (A) SLS-infected laboratory rabbit: Day 10. Arrow indicates
fected wild rabbit: Day 10. Arrow indicates blood vessel. Scale bar, 100
cted wild rabbit: 15 days. Scale bar, 100 mm.was a general depletion of lymphocytes and proliferation
and degeneration of reticular cells, with a limited influx of
c fter inf
84 BEST, COLLINS, AND KERRinflammatory cells. The pathology was most severe in
spleens of SLS-infected laboratory rabbits. At 10 days
these were depleted of lymphocytes and engorged with
red cells so that the red and white pulp were not clearly
defined. There was an inflammatory influx of neutrophils
and many macrophages contained cellular debris within
their cytoplasm. Germinal centers were not defined. In
contrast, in spleens of wild rabbits infected with SLS, at
the same time point, there was some depletion of lym-
phocytes and infiltration of neutrophils. However, the red
and white pulp were clearly defined and there were
well-defined germinal centers. Spleens from laboratory
rabbits infected with Ur contained multiple large germi-
nal centers with no evidence of lymphocyte depletion
from the white pulp.
Virus replication in distal skin
SLS was first detected by immunofluorescence in dis-
tal skin in MHC-II-positive cells of the dermis at 4 days
after infection in one of two laboratory and in one of two
wild rabbits. At 6 days after infection virus was detected
in the distal skin of both laboratory rabbits. The infected
cells in the dermis were MHC-II positive and were evenly
distributed in the dermis. By 10 days after infection SLS
was predominantly infecting cells in the epidermis of
laboratory rabbits with few infected cells in the dermis.
Pathological changes resembled those in the primary
inoculation site at 6 days after infection. There were
inflammatory cells, predominantly polymorphs, within the
deeper layers of the dermis and some stellate myxoma
cells were present.
In Ur-infected laboratory rabbits, virus was first de-
tected in the distal skin at 6 days after infection. In wild
rabbits infected with SLS or laboratory rabbits infected
with Ur, cells positive for virus were predominantly dis-
FIG. 6. Dissemination of myxoma virus in infected cells. (A) Immu
migrating from an adjacent blood vessel in the paracortex (P) of the
inoculation. Scale bar, 25 mm. (B) Immunofluorescence staining of my
ontralateral lymph node of an SLS-infected laboratory rabbit 6 days atributed in the upper dermis and proximal to blood ves-
sels and did not have the uniform distribution in thedermis observed in SLS at the distal skin site or in the
other infections at the primary inoculation site. There
were also far fewer MHC-II-positive cells. At 10 days
after infection SLS was only present in the epidermis in
one of three wild rabbits and in the others was restricted
to the dermis. At 15 days after infection one of two of the
SLS-infected wild rabbits had a secondary lesion at the
distal skin site and virus was present in the epidermis of
both rabbits. However, it was restricted to short stretches
of 30 or so cells. At 20 days after infection two of three
SLS-infected wild rabbits had some virus present in the
epidermis. In all three rabbits, the dermis contained
numerous mononuclear inflammatory cells particularly
concentrated at the epidermal/dermal junction and
within the deep dermis. Virus was not detected by im-
munofluorescence in the epidermis of the Ur-infected
laboratory or wild rabbits at Days 15 or 20. The most
striking difference between laboratory rabbits infected
with Ur or wild rabbits infected with SLS and laboratory
rabbits infected with SLS was the infiltration of mononu-
clear cells throughout the dermis particularly by 10 days
after infection. This was most prominent in SLS-infected
wild rabbits.
Cell death in lymph nodes and spleen
Depletion of lymphocytes was a major feature of
SLS infection of lymph nodes of laboratory and wild
rabbits. To investigate the role of apoptosis in cell
death in the lymph nodes, sections were stained by
TUNEL reaction. Large numbers of positively stained
cells were evenly distributed across the paracortex of
the draining lymph nodes from all myxoma virus-in-
fected rabbits whereas in uninfected control sections
apoptotic cells were far fewer and tended to be clus-
tered in germinal centers (Fig. 7). The numbers of
escence staining of myxoma virus-infected cells (example arrowed)
lateral lymph node of an SLS-infected laboratory rabbit 6 days after
irus-infected cells (example arrowed) in the subcapsular sinus of the
ection. C, capsule. Scale bar, 15 mm.nofluor
contra
xoma vapoptotic cells were compared between infections
and are shown in Fig. 8. Apoptosis was a major feature
n ining l
85CELLULAR LOCALIZATION OF MYXOMA VIRUSof SLS-infected laboratory rabbits by 4 days after in-
fection and in the other groups by 6 days after infec-
tion and was present even when most virus had been
cleared from the nodes at Days 15 and 20.
There were only small numbers of apoptotic cells in
the spleen compared to the lymph nodes (Fig. 8C). How-
ever, in SLS-infected laboratory rabbits by 10 days after
infection there were substantially less apoptotic cells in
the spleens than in the other groups.
Double staining of sections for apoptosis and virus
suggested that the apoptotic cells were not virus in-
fected (data not shown). This was confirmed by examin-
ing serial sections stained either for virus or for apopto-
sis. Apoptotic cells were often adjacent to or close by
virus-infected cells but did not contain viral antigen (Figs.
9A and 9B). In SLS-infected laboratory rabbits, virus-
infected and apoptotic cells were a feature of germinal
centers as well as the paracortical cells (Figs. 9C and
9D). Widespread apoptosis also occurred in the absence
of detectable virus-infected cells (Figs. 9E and 9F). An
increased number of apoptotic cells in germinal centers
was seen in other infections but these were confined to
FIG. 7. TUNEL staining of lymph nodes from myxoma virus-infected ra
bar, 250 mm. (B) Laboratory rabbit infected with SLS, draining lymph nod
ode Day 10. Scale bar, 250 mm. (D) Wild rabbit infected with SLS, drathe outer edges of the dark zone and did not involve the
entire germinal center.Sequence analysis of the Serp 2 gene from SLS
and Ur
It has been proposed that the serine proteinase inhib-
itor Serp 2 (myxoma virus gene M151R (Cameron et al.,
1999)) encoded by myxoma virus may have a role in
preventing lymphocyte apoptosis in lymph nodes (Mes-
sud-Petit et al., 1998). These authors observed apoptosis
in lymphocytes in lymph nodes from laboratory rabbits
infected with Serp 2 knock-out virus but not from rabbits
infected with the wild-type T1 French strain of myxoma
virus. As we had shown large-scale apoptosis in lymph
nodes during infections with both SLS and Ur, this sug-
gested that there may have been sequence differences
or even loss of the Serp 2 gene in the SLS virus released
into Australia. To examine this, the Serp 2 genes were
amplified by PCR from Lausanne (French strains of myx-
oma virus are derived from Lausanne (Fenner and Rat-
cliffe, 1965)), SLS, and Ur and sequenced. A complete
coding sequence was present for Serp 2 in all three
viruses and there were no nucleotide differences found
among the three viruses (GenBank Accession Nos.:
325366, 325375, and 325377). There were four nucleotide
A) Normal rabbit lymph node. GC, germinal center; P, paracortex. Scale
10. Scale bar, 250 mm. (C) Ur-infected laboratory rabbit, draining lymph
ymph node Day 10. Scale bar, 250 mm.bbits. (
e Daydifferences in the sequences we obtained compared to
the sequence published by Petit et al. (1996); all of these
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86 BEST, COLLINS, AND KERRwould lead to amino acid changes: Thr (72)-Lys; Val
(76)-Ala; Asp (127)-Ala; Ile (142)-Phe. However, the se-
quences we obtained were identical to that published for
Serp 2 (M151R) from the Lausanne strain by Cameron et
al. (1999). These amino acid changes are not within the
C-terminal region of the protein where the active center
for serine proteinase binding is believed to be (Petit et
al., 1996). Thus while we have not done a functional
analysis of the Serp 2 protein from these viruses, based
on the sequencing studies we do not believe that the
apoptosis in lymph nodes of rabbits infected with either
SLS or Ur was due to significant mutations in the Serp 2
gene.
DISCUSSION
FIG. 8. Mean numbers of TUNEL 1 cells per 10,000 mm2 in lymph
odes and spleens of myxoma virus infected rabbits. Error bars show
tandard error calculated using all tissue sections for all rabbits. Note
hat Day 2 did not differ from uninfected nodes. (A) Draining lymph
ode. (B) Contralateral lymph node. (C) Spleen.Resistance to myxoma virus represents a gradation in
clinical and pathological effects which depends on thevirulence of the virus and the resistance of the rabbit. In
the early stages of infection, SLS in laboratory rabbits is
the most virulent, followed by SLS in wild rabbits and
then Ur in laboratory rabbits. Ur in wild rabbits is quite
innocuous. However, wild rabbits recovered from infec-
tion with SLS somewhat earlier than laboratory rabbits
infected with Ur. This suggests that resistance cannot be
simply modeled by examining the pathogenesis of atten-
uated virus strains in laboratory rabbits.
There were three important features of myxoma virus
pathogenesis observed. First, the virus replicated in cells
mediating the antiviral immune response. Initially virus
replication occurred in MHC-II-positive dendritic-like
cells in the dermis. These are probably dermal dendritic
cells and Langerhan’s cells, based on their location,
morphology, and MHC-II staining, but this has not for-
mally been demonstrated because of a lack of markers
for rabbit dendritic cells. These cells are also likely to be
responsible for transporting virus to the draining lymph
node. Within the lymph node, the virus infected lympho-
cytes in the T cell zone. These infected lymphocytes may
be responsible for transporting virus around the body.
The second feature was the depletion of lymphocytes
from the lymph nodes of SLS-infected rabbits and the
induction of widespread apoptosis in lymphocytes of all
infected rabbits. Infection with Ur did not cause lympho-
cyte depletion but was still associated with widespread
lymphocyte apoptosis.
The third feature was the difference in the inflamma-
tory response between laboratory and wild rabbits and
between virulent and attenuated viruses. In laboratory
rabbits infected with SLS, the predominant inflammatory
cells were polymorphs. However, mononuclear cells
comprised a large part of the cellular response in wild
rabbits and in Ur infections.
If myxoma virus is replicating within dendritic cells,
which are responsible for inducing a large part of the
adaptive immune response (Banchereau and Steinman,
1998), this could have several effects. First, it may inhibit
antigen presentation. Myxoma virus downregulates
MHC-I molecules on the surface of infected cells (Bosh-
kov et al., 1992; Zuniga et al., 1999) and thus may reduce
ntigen presentation to cytotoxic T lymphocytes (CTLs).
n addition, binding proteins that inhibit IFN-g (Upton et
al., 1992), TNF (Upton et al., 1991), and chemokines
(Graham et al., 1997; Lalani et al., 1997, 1998) are se-
creted from myxoma virus-infected cells. These proteins
might also prevent the development of a type-1 cytokine
millieu at the site of inoculation and within the dendritic
cell-lymphocyte microenvironment of the lymph node
and thus prevent an effective antiviral immune response
developing (Karupiah, 1998). By inhibiting chemokines
the virus may prevent the influx of lymphocytes and other
antiviral effector cells to the target tissues. Other virus
proteins such as the secreted Serp 1 (Macen et al., 1993)
and membrane-localized M11L (Graham et al., 1992)
(
ls in ma
ined fo
87CELLULAR LOCALIZATION OF MYXOMA VIRUShave also been shown to significantly downregulate the
inflammatory response at the inoculation site. Production
of these inhibitory mediators of the immune response by
virus-infected dendritic cells could inhibit innate and
adaptive antiviral immune responses. Infection of den-
dritic cells in vitro by the orthopoxvirus vaccinia virus
downregulated activation and maturation of these cells
although vaccinia was unable to productively infect the
FIG. 9. Colocalization of virus-infected and apoptotic cells in lymph n
from SLS-infected laboratory rabbit at Day 4 after infection. F, follicle; P, p
C) Tunel-stained cells in germinal center (GC) from SLS-infected labor
in serial section from C. (Note different distribution of virus-stained cel
6. GC, germinal center. Scale bar, 90 mm. (F) Serial section from E stacells and only early proteins were expressed (En-
glemayer et al., 1999). Similarly measles virus infection ofdendritic cells suppresses both survival and function of
these cells (Fugier-Vivier et al., 1997; Grosjean et al.,
1997).
Both the virulent SLS and the attenuated Ur replicated
in MHC-II-positive dendritic-like cells. Thus cell tropism
was not responsible for the attenuated phenotype of the
Ur strain. In contrast, tropism for denditic cells is a
function of virulence in mice infected with virulent lym-
f myxoma virus-infected rabbits. (A) Tunel-stained draining lymph node
tex. Scale bar, 90 mm. (B) Serial section from A stained for viral antigen.
abbit at Day 6 after infection. Scale bar, 90 mm. (D) Virus-stained cells
ntle zone.) (E) Tunel-stained cells in Ur-infected laboratory rabbit Day
r viral antigen.odes o
aracor
atory rphocytic choriomeningitis virus (Borrow et al., 1995). Sim-
ilarly SLS replicated in MHC-II-positive dendritic-like
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88 BEST, COLLINS, AND KERRcells in both wild (resistant) and laboratory (susceptible)
rabbits. Thus resistance to myxoma virus was not be-
cause these cells were resistant to virus infection.
As well as infecting MHC-II-positive cells, myxoma
virus infected lymphocytes in the T cell zone of the lymph
nodes and virulent virus induced significant depletion of
lymphocytes from infected laboratory rabbits. As a model
for the depletion of lymphocytes in infected rabbits we
suggest that infection of cells with virulent SLS induces
lymphocyte death and an ongoing depletion of lympho-
cytes from the node. There is a failure to repopulate the
node. In the attenuated Ur infections, there is an influx of
lymphocytes into the node and local proliferation as part
of an active immune response; many of these cells un-
dergo apoptosis, however, the influx and proliferation of
cells more than compensate for the loss. Infection of wild
rabbits with SLS causes ongoing cell death and deple-
tion of lymphocytes but there is also an influx and pro-
liferation of lymphocytes and between 10 and 15 days the
influx outweighs the cell death and the nodes are repop-
ulated with cells.
Apoptotic cells were predominantly within the T cell
zone of the lymph node, where the virus was replicating,
although in SLS infection a considerable amount of
apoptosis was also observed within follicles and these
follicles also stained positively for virus. As far as we
could show, using serial sections and double staining,
cells containing viral antigen did not undergo apoptosis
but cells adjacent to infected cells did. In addition,
apoptotic cells continued to be present in high numbers
long after virus-infected cells could no longer be found.
Apoptosis in bystander lymphocytes has been described
for virus infections such as HIV-1 and SIV-1 both in vitro
and in vivo (Finkel et al., 1995; Herbein et al., 1998b) and
HV-6 in vitro (Inoue et al., 1997). Several explanations
re possible for the apoptosis observed in myxoma vi-
us-infected lymph nodes. First, cells infected with myx-
ma virus could be primed to rapidly undergo apoptosis
efore the expression of late proteins detected by immu-
ostaining. Therefore these cells would not stain posi-
ively for myxoma virus antigen. Myxoma virus encodes
t least four proteins which prevent apoptosis of infected
cells in vitro (McFadden and Barry, 1998; Nash et al.,
999); however, in vivo there may be significant external
ignals in the form of cytokines or ligand interactions
nfluencing the cells. Secondly, some antigen-specific
ells may be partially activated by presentation of viral
ntigens by dendritic cells but failure of second signals
ay induce apoptosis. Thirdly, virus-infected cells may
roduce a signal or signals which induce apoptosis in
eighboring cells in vivo (Herbein et al., 1998a). The
ontinuation of apoptosis in lymph nodes beyond the
eriod when virus could be detected may be due to a
ery active immune response with many activated ornappropriately activated cells being deleted (Walsh and
cNally, 1999).
U
UIn resistant rabbits, or infections with attenuated virus,
here was still dissemination of virus from the skin and
raining lymph node to the distal tissues such as lymph
odes and skin. However, both viral replication as seen
y immunofluorescence and tissue pathology were con-
trained in distal tissues and differences in virus titers
ere seen as early as 4 days after infection (Best and
err, 2000). In particular titers of SLS in the draining
ymph node were 10- to 100-fold lower in wild rabbits
han laboratory rabbits. Based on a model for resistance
o ectromelia virus in mice (Karupiah, 1998), we suggest
hat infection of resistant rabbits with SLS or susceptible
abbits with Ur leads to a type 1 cytokine response with
igh IFN-g levels, an NK cell response, and the devel-
pment of an appropriate antiviral CTL response. This
mmune response controls virus replication in both drain-
ng lymph node and distal sites but is not sufficient to
ontrol virus replication at the primary inoculation site or
o prevent virus spreading to distal sites. In contrast, this
odel suggests that infection of susceptible rabbits with
LS leads to a type 2 immune cytokine response domi-
ated by IL-4 and IL-10 and failure to control the virus.
The inflammatory response in wild rabbits was domi-
ated by mononuclear cells (lymphocytes and mono-
ytes) and occurred close to where the virus was repli-
ating whereas in domestic rabbits infected with SLS it
as predominantly neutrophils and was often some dis-
ance from where the main virus replication was occur-
ing. The T1 (M001L/R) chemokine-binding protein of
yxoma virus inhibits the migration of mononuclear cells
n vitro by binding b-chemokines but does not inhibit the
igration of neutrophils stimulated by a-chemokines
(Lalani et al., 1998). This raises the possibility that part of
the genetic resistance and attenuation phenotype may
be due to an enhanced b-chemokine response. The
ecent demonstration that the chemokine receptor pro-
eins may be involved in cell entry by myxoma virus
Lalani et al., 1999) provides a potential mechanism for
esistance by which expression of elevated levels of
hemokines by wild rabbits could block receptor binding
ites.
MATERIALS AND METHODS
iruses
The Standard Laboratory Strain of myxoma virus (SLS)
sed in this study was derived from a freeze-dried rabbit
issue stock prepared by Professor Frank Fenner (John
urtin School of Medical Research, Canberra, Australia)
n 1953. This was passaged twice in RK13 cells and twice
n rabbits. The virus is of grade 1 virulence (Fenner and
arshall, 1957) killing 100% of infected laboratory rabbits
ith an average survival time of ,13 days and this was
onfirmed prior to this study (Robinson et al., 1999). The
riarra (Ur) strain of myxoma virus was derived from the
riarra/2/53-1 isolate (Mykytowycz, 1953) by Russell and
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89CELLULAR LOCALIZATION OF MYXOMA VIRUSRobbins (1989). It was passaged an unknown number of
times in CV-1 cells before we obtained it and subse-
quently was passaged twice in Sirc cells and twice in
rabbits. This virus is of grade 5 virulence and over 95% of
laboratory rabbits recover from infection but all develop
clinically severe myxomatosis (Fountain et al., 1997; Kerr
npublished). The Lausanne (Brazil/Campinas 1949)
train of myxoma virus was derived by two rabbit pas-
ages from a commercial stock produced in 1973 by the
ommonwealth Serum Laboratories, Melbourne, Austra-
ia Virus stocks of SLS or Ur were prepared as testis
omogenates from laboratory rabbits. Titers were deter-
ined by plaque assay on Vero cell monolayers.
abbit breeding and housing
All animal experiments followed CSIRO/NHMRC
uidelines for animal usage and were approved by the
SIRO Wildlife and Ecology animal experimentation eth-
cs committee.
Laboratory rabbits were bred at the CSIRO Wildlife and
cology animal facility and were an outbred line of pre-
ominantly New Zealand White stock. Wild rabbits were
red in floor pens in the same animal facility; breeding
tock was derived from rabbits captured as kittens in the
anberra district. The animals used for experiments
ere one to two generations removed from the wild.
here was no selection for resistance to myxomatosis in
he breeding facility.
For experimental use all rabbits were housed in indi-
idual cages in a temperature- and light-controlled (12 h
ight/12 h dark/21°C) animal room. Standard rabbit pel-
ets and water were provided ad libitum and green veg-
etables were supplied weekly. Shelters were provided in
each cage as a refuge for the wild rabbits.
Only male rabbits were used in the experiments and
all rabbits used were more than 4 months old.
Infections and monitoring of rabbits
Laboratory rabbits were inoculated with 100 PFU of
either SLS (12 rabbits) or Ur (16 rabbits) intradermally
into the dorsum of the left hind foot. Wild rabbits were
inoculated in the same way but 20 rabbits were inoc-
ulated with each virus. Two laboratory rabbits infected
with SLS were killed at each of 12 and 24 h and 2, 4,
6, and 10 days after inoculation. Two laboratory rabbits
infected with Ur were killed at each of 12 and 24 h and
2, 4, 6, 10, 15, and 20 days after inoculation. For wild
rabbit infections with SLS or Ur, 2 rabbits were killed at
12 and 24 h and 2 and 4 days after infection and 3
rabbits at 6, 10, 15, and 20 days after inoculation.
Rabbits were randomly allocated to killing times prior
to inoculation and killed by an intravenous overdose of
barbiturate.
i
iTissue collection and processing
At autopsy the skin inoculation site, the left popliteal
lymph node (draining lymph node), right popliteal lymph
node (contralateral node), skin from the equivalent site
on the right hind foot to the inoculation site (distal skin),
and spleen were collected. Tissue portions were fixed in
10% buffered formalin and embedded in paraffin wax for
histological processing. Four 5-mm sections were cut
from each tissue at intervals of 500 mm. Sections were
tained with hematoxylin and eosin. The remainder of
ach tissue was used to determine virus titers. These
iters have been described elsewhere (Best and Kerr,
000).
Tissue slices for frozen sections were covered in OTC
mbedding fluid (Tissue Tek), frozen in liquid nitrogen,
nd stored at 270°C. Cryostat sections were cut at 4–7
mm onto poly-L-lysine-treated slides, fixed in formol-cal-
cium (10% v/v formalin, 10% v/v 1 M CaCl2, 80% v/v H2O),
ipped in cold acetone, immersed in chloroform:acetone
1:1 v/v) for 5 min at 220°C, dipped in cold acetone,
ashed twice in PBS, and stored at 270°C.
mmunostaining for myxoma virus localization
Frozen tissue sections were blocked overnight in 3%
SA w/v in PBS at room temperature and washed with
% BSA/PBS. Sections were placed in a humidified con-
ainer and covered with 1:200 dilution of mouse anti-
yxoma virus monoclonal antibody (clone 3B6E4; Foun-
ain et al., 1997) in 1% BSA/PBS. In immunoblots, using
oncentrated virus as antigen, this antibody binds to an
pproximately 42-kDa late protein that, in infected RK13
ells, is not expressed at 2 or 4 h after infection but is
trongly expressed from 6 h after infection (P. J. Kerr,
npublished). Two controls were used for each section:
ormal mouse ascites fluid and no primary antibody.
ncubation was for 2 h at 37°C followed by three washes
ith 0.01% v/v Tween 20 in PBS. Goat anti-mouse Ig
onjugated to FITC (Boehringer Mannheim), 75 ml of a
1:50 dilution in 1% BSA/PBS was added, and sections
were incubated in the dark for 60 min at 37°C. After
washing in Tween/PBS sections were mounted in Anti-
fade (Molecular Probes, OR) and visualized using a con-
focal microscope. Staining for rabbit MHC-II followed the
same protocol using the mouse anti-rabbit monoclonal
antibody 2C4 (MHC II R-DQ) at a 1:10 dilution (Serotec,
NC) (Lobel and Knight, 1984). Double staining for virus
and MHC-II used 2C4 as the initial antibody followed by
goat-anti-mouse-FITC. After washing, 100 ml of 1:50
heep-anti-mouse Ig (Silenus, Hawthorn Australia) was
dded to each section, incubated for 60 min at 37°C, and
he second primary antibody (3B6E4) was added. After a
0-min incubation at 37°C and washing, 50 ml of 1:10
heep anti-mouse Ig conjugated to rhodamine (Boehr-nger Mannheim) was added followed by a further 60-min
ncubation. Sections were washed and mounted as
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90 BEST, COLLINS, AND KERRabove. For each section used in double staining the
section cut immediately before or after it was used for
single staining for myxoma virus or MHC-II.
TUNEL reaction
Tissues were fixed in 10% buffered formalin, paraffin
embedded, and sectioned onto 0.1% poly-L-lysine-coated
slides. The sections were dewaxed with xylene and then
passed through a graded ethanol series to water. Sec-
tions were then soaked in 23 SSC for 20 min at 80°C
soaked in water for 10 min at room temperature, and
immersed in prewarmed 0.1 M Tris/EDTA at 42°C for 2
min. Sections were placed in an humidified container
and covered with 100 ml of 0.1 mg/ml proteinase K in 0.1
Tris/EDTA for 10 min at 37°C followed by a rinse in
ater. Sections were blocked in 1% BSA (w/v) in PBS for
min at room temperature and then permeabilized for 2
in at 4°C in 0.1% (w/v) sodium citrate, 1:1000 Triton
-100 followed by two washes with PBS. Sections were
eturned to the humidified container and covered with 50
ml of terminal transferase reaction mix (31 ml water, 10 ml
53 TdT buffer, 2 ml CoCl2, 3 ml 1 mM dATP, 2 ml, 1:100
dUTP-FITC, 1 ml TdT (all reagents from Boehringer Mann-
heim), for 1 h at 37°C. The reaction was stopped by the
addition of 50 ml 0.05 M EDTA. Reaction mix without
erminal transferase was used as a negative control.
ositive controls of rabbit ovary and negative controls of
abbit liver were used in each reaction set. To provide
ackground controls, sections of lymph nodes from 11
ndividual uninfected rabbits were stained for apoptosis
y TUNEL reaction. Sections were mounted using anti-
ade and viewed using a confocal microscope. To quan-
itate the number of apoptotic cells, a grid was superim-
osed on the 310 field of view and the number of cells
tained was counted. Counting was segregated into dif-
erent zones of the lymphoid tissue. Four fields of view
ere used for each section of lymph node and five for
ach section of spleen. Three different sections were
sed from each tissue for each rabbit. The number of
ositive cells was expressed as mean 1/2 standard
rror and included all counts for a group of infected
abbits killed at the same time point.
taining sections for myxoma virus and apoptosis
Double staining was done by first staining frozen sec-
ions for myxoma virus as described above but using a
heep-anti-mouse Ig rhodamine conjugate. Sections
ere then processed for the TUNEL reaction as de-
cribed above but omitting the 23 SSC treatment, pro-
einase K treatment, and permeabilization treatments as
he tissue had already been permeabilized during fixa-
ion. To confirm that signal for virus or apoptosis was not
eing lost during the double labeling, sequential serial
ections were stained for either myxoma virus or with the
UNEL reaction.maging and section analysis
For each rabbit at least three sections were examined
rom every tissue for histology and immunofluorescence
taining for virus.
CR amplification and sequence analysis of the Serp
gene
The Serp 2 gene was amplified by polymerase chain
eaction (PCR) from RK13 cells infected with either Lu,
LS, or Ur using oligonucleotide primers designed from
he published sequence (Petit et al., 1996): 59-AGAG-
TATAATGTATAAGTGC-39; 59-CTAACGGATACAGGAGAG-
9. Cloning into pGem T easy (Promega) and sequence
nalysis by Big Dye terminator cycle sequencing (PE
iosystems, CA) followed the manufacturer’s protocols.
ACKNOWLEDGMENTS
We thank Dr. Peter Janssens and Dr. Tony Robinson for many helpful
discussions. Louise Silvers provided technical assistance. Part of this
study was funded by a grant from the Foundation for Rabbit Free
Australia (formerly the Anti Rabbit Research Foundation of Australia).
REFERENCES
Anderson, R. M., and May, R. M. (1982). Coevolution of hosts and
parasites. Parasitology 85, 411–426.
Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the
control of immunity. Nature 392, 245–253.
Best, S. M., and Kerr, P. J. (2000). Coevolution of host and virus: The
pathogenesis of virulent and attenuated strains of myxoma virus in
resistant and susceptible European rabbits. Virology 267, 36–48.
Borrow, P., Evans, C. F., and Oldstone, M. B. A. (1995). Virus induced
immunosuppression: Immune system-mediated destruction of virus-
infected dendritic cells results in generalized immune suppression.
J. Virol. 69, 1059–1070.
Boshkov, L. K., Macen, J. L., and McFadden, G. (1992). Virus induced
loss of class I MHC antigens from the surface of cells infected with
myxoma virus and malignant rabbit fibroma virus. J. Immunol. 148,
881–887.
Cameron, C., Hota-Mitchell, S., Chen, L., Barrett, J., Cao, J.-X., Macaulay,
C., Willer, D., Evans, D., and McFadden, G. (1999). The complete DNA
sequence of myxoma virus. Virology 264, 298–318.
Englemayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I.,
Steinman, R. M., and Bhardwaj, N. (1999). Vaccinia virus inhibits the
maturation of human dendritic cells: A novel mechanism of immune
evasion. J. Immunol. 163, 6762–6768.
Fenner, F. (1983). Biological control as exemplified by smallpox eradi-
cation and myxomatosis. Proc. R. Soc. London B 218, 259–285.
Fenner, F., and Marshall, I. D. (1957). A comparison of the virulence for
European rabbits (Oryctolagus cuniculus) of strains of myxoma virus
recovered in the field in Australia, Europe and America. J. Hyg.
(Cambridge) 55, 149–151.
Fenner, F., and Ratcliffe, F. N. (1965). “Myxomatosis.” Cambridge Univ.
Press, Cambridge, England.
Fenner, F., and Ross, J. (1994). Myxomatosis. In “The European Rabbit.
The History and Biology of a Successful Colonizer” (H. V. Thompson
and C. M. King, Eds.), pp. 205–240. Oxford Univ. Press, Oxford.
Fenner, F., and Woodroofe, G. M. (1953). The pathogenesis of infectious
myxomatosis: The mechanism of infection and the immunological
response in the European rabbit (Oryctolagus cuniculus). Br. J. Exp.
Pathol. 34, 400–410.
Finkel, T. H., G., T.-W., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C.,
91CELLULAR LOCALIZATION OF MYXOMA VIRUSBaba, T. W., Ruprecht, R. M., and Kupfer, A. (1995). Apoptosis occurs
predominantly in bystander cells and not in productively infected cell
of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129–134.
Fountain, S., Holland, M. K., Hinds, L. A., Janssens, P. A., and Kerr, P. J.
(1997). Interstitial orchitis with impaired steroidogenesis and sper-
matogenesis in the testes of rabbits infected with an attenuated
strain of myxoma virus. J. Reprod. Fertil. 110, 161–169.
Fugier-Vivier, I., Servet-Delprat, C., Rivailler, P., Rissoan, M.-C., Liu, Y.-J.,
and Rambourdin-Combe, C. (1997). Measles virus suppresses cell-
mediated immunity by interfering with the survival and functions of
dendritic and T cells. J. Exp. Med. 186, 813–823.
Graham, K. A., Opgenorth, A., Upton, C., and Mcfadden, G. (1992).
Myxoma virus M11l orf encodes a protein for which cell surface
localization is critical in manifestation of viral virulence. Virology 191,
112–124.
Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L.-Y.,
Lucas, A., Clark-Lewis, I., Moyer, R. W., and McFadden, G. (1997). The
T1/35kDa family of poxvirus-secreted proteins bind chemokines and
modulate leukocyte influx into virus-infected tissues. Virology 229,
12–24.
Grosjean, I., Caux, C., Bella, C., Berger, I., Wild, F., Banchereau, J., and
Kaiserlian, D. (1997). Measles virus infects human dendritic cells and
blocks thier allostimulatory properties. J. Exp. Med. 186, 801–812.
Herbein, G., Mahlknecht, U., Batliwalla, F., Gregerson, P., Pappas, T.,
Butler, J., O’Brien, W. A., and Verdin, E. (1998a). Apoptosis of Cd81 T
cells is mediated by macrophages through interaction of HIV gp 120
with chemokine receptor CXCR4. Nature 395, 189–194.
Herbein, G., van Lint, C., Lovett, J. L., and Verdin, E. (1998b). Distinct
mechanisms trigger apoptosis in human immunodeficiency virus typ
1-infected and in uninfected bystander T lymphocytes. J. Virol. 72,
660–670.
Hurst, E. W. (1937). Myxoma and the Shope fibroma. I. The histology of
myxoma. Br. J. Exp. Pathol. 18, 1–15.
Inoue, Y., Yasukawa, M., and Fujita, S. (1997). Induction of T-cell apo-
ptosis by human herpesvirus 6. J. Virol. 71, 3751–3759.
Karupiah, G. (1998). Type 1 and type 2 cytokines in antiviral defense.
Vet. Immunol. Immunopathol. 63, 105–109.
Kerr, P. J., and Best, S. M. (1998). Myxoma virus in rabbits. Rev. Sci. Tech.
Off. Int. Epiz. 17, 256–268.
Lalani, A. S., Graham, K., Mossman, K., Rajarathnam, K., Clark-Lewis, I.,
Kelvin, D., and McFadden, G. (1997). The purified myxoma virus
gamma interferon receptor homolog M-T7 interacts with the heparin-
binding domains of chemokines. J. Virol. 71, 4356–4363.
Lalani, A. S., Masters, J., Zeng, W., Barrett, J., Pannu, R., Everett, H.,
Arendt, C. W., and McFadden, G. (1999). Use of chemokine receptors
by poxviruses. Science 286, 1968–1971.
Lalani, A. S., Ness, T. L., Singh, R., Harrison, J. K., Seet, B. T., Kelvin, D. J.,
McFadden, G., and Moyer, R. W. (1998). Functional comparisons
among members of the poxvirus T1/35 kDa family of soluble CC-
chemokine inhibitor glycoproteins. Virology 250, 173–184.
Lobel, S. A., and Knight, K. L. (1984). The role of rabbit Ia molecules in
immune functions as determined with the use of an anti-Ia mono-
clonal antibody. Immunology 51, 35–43.
Macen, J., L., Upton, C., Nation, N., and McFadden, G. (1993). Serp 1, a
secreted proteinase inhibitor encoded by myxoma virus is a secreted
glycoprotein that interferes with inflammation. Virology 195, 348–363.Marshall, I. D., and Douglas, G. W. (1961). Studies in the epidemiol-
ogy of infectious myxomatosis of rabbits. VIII. Further obser-
vations on changes in the innate resistance of Australian
wild rabbits exposed to myxomatosis. J. Hyg. (Cambridge) 59,
117–122.
Marshall, I. D., and Fenner, F. (1958). Studies in the epidemiology of
infectious myxomatosis of rabbits. V. Changes in the innate resis-
tance of Australian wild rabbits exposed to myxomatosis. J. Hyg.
(Cambridge) 56, 288–302.
McFadden, G., and Barry, M. (1998). How poxviruses oppose apoptosis.
Sem. Virol. 8, 429–442.
Messud-Petit, F., Gelfi, J., Delverdier, M., Amardeilh, M.-F., Py, R., Sutter,
G., and Bertagnoli, S. (1998). Serp 2, an inhibitor of the interleukin-
1b-converting enzyme, is critical in the pathobiology of myxoma
virus. J. Virol. 72, 7830–7839.
Mykytowycz, R. (1953). An attenuated strain of the myxomatosis virus
recovered from the field. Nature (London) 172, 448–449.
Nash, P., Barrett, J., Cao, J.-X., Hota-Mitchell, S., Lalani, L. S., Everett, H.,
Xu, X.-M., Robichaud, J., Hnatiuk, S., Ainslie, C., Seet, B. T., and
McFadden, G. (1999). Immunomodulation by viruses: The myxoma
virus story. Immunol. Rev. 168, 103–120.
Padget, B. L., Wright, M. J., Jayne, A., and Walker, D. L. (1964). Electron
microscopic structure of myxoma virus and some reactivable deriv-
atives. J. Bacteriol. 87, 454–460.
Payne, L. G. (1980). Significance of extracellular enveloped virus in the
in vitro and in vivo dissemination of vaccinia virus. J. Gen. Virol. 50,
89–100.
Petit, F., Bertagnoli, S., Gelfi, J., Fassy, F., Boucrat-Baralon, C., and Milon,
A. (1996). Characterization of a myxoma virus encoded serpin-like
protein with activity against interleukin-1b-converting enzyme. J. Vi-
rol. 70, 5860–5866.
Robinson, A. J., Muller, W. J., Braid, A., and Kerr, P. J. (1999). The effect
of buphrenorphine on the course of disease in laboratory rabbits
infected with myxoma virus. Lab. Anim. Sci., In press.
Russell, R. J., and Robbins, S. J. (1989). Cloning and molecular charac-
terization of the myxoma virus genome. Virology 170, 147–159.
Upton, C., Macen, J. L., Schreiber, M., and McFadden, G. (1991). Myx-
oma virus expresses a secreted protein with homology to the tumour
necrosis factor receptor gene family that contributes to viral viru-
lence. Virology 184, 370–382.
Upton, C., Mossman, K., and McFadden, G. (1992). Encoding of a
homolog of the IFN-gamma receptor by myxoma virus. Science 258,
1369–1372.
Vanderplasschen, A., and Smith, G. L. (1997). A novel virus binding
assay using confocal microscopy: Demonstration that the intracellu-
lar and extracellular vaccinia virions bind to different cellular recep-
tors. J. Virol. 71, 4032–4031.
Walsh, R. M., and McNally, J. M. (1999). Immune deficiency, immune
silencing, and clonal exhaustion of T cell responses during viral
infections. Curr. Opin. Microbiol. 2, 382–387.
Zuniga, M. C., Wang, H., Barry, M., and McFadden, G. (1999). Endoso-
mal/lysosomal retention and degradation of major histocompatability
complex class I molecules is induced by myxoma virus. Virology 261,
180–192.
